Ireland
--:--IST
Priya Life Science Clinical trial register
Trackers› Clinical trials› Warsaw
Clinical trial register · Poland

Clinical Trials in Warsaw, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Poland and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 2705 matching records held by the registry are in this view. Synced 28 Oct 2026, 03:18 UTC
2705
Studies in scope
all four open statuses
1389
Recruiting now
open to new participants
512
Lead sponsors
across recruiting studies
Top sites
Katowice 16 Warsaw 14 Krakow 12 Bydgoszcz 11 Lublin 10
Narrow the registerReset
Recruitment status
Phase
Site location
Katowice16 Warsaw14 Krakow12 Bydgoszcz11 Lublin10
All 22 locations
Target enrolment
to

Trials with a site in Warsaw

14 of 2705 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Poland
Start
Recruiting
argenx
Phase 3
230
Krakow, Katowice, Bydgoszcz, Chrzanów, Lublin, Warsaw, Zamość
2026-06-10
Recruiting
argenx
Phase 2
70
Bydgoszcz, Katowice, Warsaw
2025-12-19
Recruiting
argenx
Observational
70
Bydgoszcz, Krakow, Katowice, Warsaw
2025-12-19
Recruiting
A Study to Assess the Efficacy and Safety of Empasiprubart in Adults With CIDP
NCT07091630Chronic Inflammatory Demyelinating Polyneuropathy, CIDP, Chronic Inflammatory Demyelinating Polyradiculoneuropathy
argenx
Phase 3
160
Katowice, Krakow, Warsaw
2025-09-16
Recruiting
A Study to Assess Efficacy and Safety of Empasiprubart Versus IVIg in Adults With CIDP
NCT06920004Chronic Inflammatory Demyelinating Polyneuropathy, CIDP, CIDP - Chronic Inflammatory Demyelinating Polyneuropathy
argenx
Phase 3
218
Bydgoszcz, Katowice, Krakow, Lublin, Poznan, Rzeszów, Szczecin, Warsaw
2025-08-22
Active, closed
argenx
Phase 3
154
Bydgoszcz, Katowice, Krakow, Lublin, Warsaw
2024-12-18
Active, closed
argenx
Phase 2
87
Krakow, Lublin, Nowa Sól, Warsaw, Wroclaw
2024-11-11
Recruiting
argenx
Phase 2/3
12
Gdansk, Katowice, Warsaw
2024-06-28
Recruiting
argenx
Observational
100
Bydgoszcz, Katowice, Warsaw
2024-02-13
Active, closed
argenx
Observational
413
Bydgoszcz, Katowice, Krakow, Lublin, Warsaw
2023-11-29
Recruiting
argenx
Phase 2/3
12
Gdansk, Katowice, Warsaw
2021-10-26
Rows per page Showing 1–14 of 14
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Polish investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 28 October 2026. https://priyalifescience.com/clinical-trials-poland/city/warsaw

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Poland and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 2,705 studies in total at the last sync on 28 Oct 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 14 of those studies with a site in Warsaw that also match the filters currently applied.

How many clinical trials are recruiting in Warsaw?

8 of the 14 studies on this page are recruiting new participants as of the 28 Oct 2026, 03:18 UTC sync. A further 0 have not yet opened recruitment, 5 are active but closed to new participants, and 1 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Warsaw), 14 studies
PhaseStudiesRecruitingShare
Phase 24128.6%
Phase 34328.6%
Observational3221.4%
Phase 2/33221.4%

Most active sponsors

Lead sponsors with the most studies (Warsaw)
Lead sponsorStudiesRecruiting
argenx148
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.